TY - JOUR
TI - Lenvatinib for thyroid and renal cell cancer
J2 - Aust Prescr
JF - Australian Prescriber
PY - 2017
ET - 2017/10/03
VL - 40
IS - 6
SP - 242
EP - 243
DO - 10.18773/austprescr.2017.070
LA - eng
UR - https://australianprescriber.tg.org.au/articles/lenvatinib-for-thyroid-and-renal-cell-cancer.html
KW - lenvatimib
KW - thyroid cancer
KW - renal cell cancer
KW - Lenvima
KW - Everolimus
KW - Sorafenib
PB - Therapeutic Guidelines Ltd
SN - 1839-3942
ER -